DE19706978A1 - Kombinationspräparat für oral applizierbare Antibiotika - Google Patents

Kombinationspräparat für oral applizierbare Antibiotika

Info

Publication number
DE19706978A1
DE19706978A1 DE1997106978 DE19706978A DE19706978A1 DE 19706978 A1 DE19706978 A1 DE 19706978A1 DE 1997106978 DE1997106978 DE 1997106978 DE 19706978 A DE19706978 A DE 19706978A DE 19706978 A1 DE19706978 A1 DE 19706978A1
Authority
DE
Germany
Prior art keywords
combination preparation
groups
acid
acrylic acid
preparation according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE1997106978
Other languages
German (de)
English (en)
Inventor
Ulrich Dr Posanski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE1997106978 priority Critical patent/DE19706978A1/de
Priority to PCT/EP1998/000029 priority patent/WO1998036732A2/fr
Priority to EP98905269A priority patent/EP0971691A2/fr
Priority to AU60926/98A priority patent/AU6092698A/en
Publication of DE19706978A1 publication Critical patent/DE19706978A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE1997106978 1997-02-21 1997-02-21 Kombinationspräparat für oral applizierbare Antibiotika Withdrawn DE19706978A1 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE1997106978 DE19706978A1 (de) 1997-02-21 1997-02-21 Kombinationspräparat für oral applizierbare Antibiotika
PCT/EP1998/000029 WO1998036732A2 (fr) 1997-02-21 1998-01-05 Preparation combinee pour antibiotiques administrables par voie orale
EP98905269A EP0971691A2 (fr) 1997-02-21 1998-01-05 Preparation combinee pour antibiotiques administrables par voie orale
AU60926/98A AU6092698A (en) 1997-02-21 1998-01-05 Combination preparation for orally administered antibiotics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1997106978 DE19706978A1 (de) 1997-02-21 1997-02-21 Kombinationspräparat für oral applizierbare Antibiotika

Publications (1)

Publication Number Publication Date
DE19706978A1 true DE19706978A1 (de) 1998-08-27

Family

ID=7821094

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1997106978 Withdrawn DE19706978A1 (de) 1997-02-21 1997-02-21 Kombinationspräparat für oral applizierbare Antibiotika

Country Status (4)

Country Link
EP (1) EP0971691A2 (fr)
AU (1) AU6092698A (fr)
DE (1) DE19706978A1 (fr)
WO (1) WO1998036732A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003053399A2 (fr) * 2001-12-21 2003-07-03 Pfizer Products Inc. Procedes de granulation par voie humide d'azithromycine
US6872407B2 (en) 1997-04-11 2005-03-29 Abbott Laboratories Extended release formulations of erythromycin derivatives

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9815532D0 (en) * 1998-07-17 1998-09-16 Lek Pharmaceutical & Cvhemical Pharmaceutical suspension formulation
GB9930578D0 (en) * 1999-12-23 2000-02-16 Smithkline Beecham Plc Pharmaceutical formulations
MX2014001556A (es) 2011-08-12 2014-03-31 Boehringer Ingelheim Vetmed Composicion farmaceutica de sabor enmascarado.
WO2014122248A1 (fr) 2013-02-11 2014-08-14 Boehringer Ingelheim Vetmedica Gmbh Kit d'éléments

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
GB9114950D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
JP3265680B2 (ja) * 1992-03-12 2002-03-11 大正製薬株式会社 経口製剤用組成物
IT1270594B (it) * 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872407B2 (en) 1997-04-11 2005-03-29 Abbott Laboratories Extended release formulations of erythromycin derivatives
WO2003053399A2 (fr) * 2001-12-21 2003-07-03 Pfizer Products Inc. Procedes de granulation par voie humide d'azithromycine
WO2003053399A3 (fr) * 2001-12-21 2004-05-21 Pfizer Prod Inc Procedes de granulation par voie humide d'azithromycine

Also Published As

Publication number Publication date
WO1998036732A2 (fr) 1998-08-27
AU6092698A (en) 1998-09-09
EP0971691A2 (fr) 2000-01-19
WO1998036732A3 (fr) 1998-10-22

Similar Documents

Publication Publication Date Title
US5626875A (en) Stabilized galenic formulations comprising an acid labile benzimidazole compound and its preparation
EP0293885B1 (fr) Compositions contenant une association antibiotique-polymère
DE3050131C2 (fr)
DE60011617T2 (de) Zeitgesteuert freisetzende dosierungsformen enthaltend ein kurz wirksames hypnotikum oder ein salz davon
KR100474793B1 (ko) 트라마돌 다중 단위 제형 및 이의 제조방법
EP2645996B1 (fr) Procédés pour la preparation d'une composition comprennant d'inhibiteurs de la pompe à protons
EP0720473B1 (fr) Pellets de budesonide a liberation controlee et leur procede de preparation
AT396329B (de) Pharmazeutische granulate und verfahren zu ihrer herstellung
DD146547A5 (de) Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
DE60108255T2 (de) Clarithromycin enthaltende zubereitung mit verlängerter freisetzung
EP0032562A1 (fr) Formes-retard pour l'administration du dipyridamol et procédés pour leur préparation
AT500063A1 (de) Beschichtete tablettenkerne
EP1315481B1 (fr) Medicament pour le traitement de maladies intestinales
WO1999015172A1 (fr) Formulation medicamenteuse a liberation controlee du principe actif
WO2006030297A1 (fr) Granules au gout masque comprenant de la clarithromycine, des hydrocolloides et un revetement
DE60006362T2 (de) Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen
WO2006069920A1 (fr) Formes galeniques a liberation rapide pour antibiotiques
DE19706978A1 (de) Kombinationspräparat für oral applizierbare Antibiotika
MXPA00011364A (es) Forma farmaceutica de multiparticulas de liberacion programada y de tiempo y su procedimiento de preparacion.
DE3839825C2 (fr)
EP0971718B1 (fr) Preparation combinee pour l'administration par voie orale d'erythromycine
DE4122167A1 (de) Tablette und granulat enthaltend als wirkstoff mesna
DE19835823A1 (de) Pharmazeutische Zusammensetzung, Verfahren zu ihrer Herstellung und ihre Verwendung sowie aus ihr hergestellte wässerige Suspension
GB2083749A (en) Drug combination comprising ambroxol and an antibiotic for the treatment of infectious diseases of the respiratory tract
EP0768882A1 (fr) Medicament a la carbamazepine a liberation retardee du principe actif

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee